Isao Moritani

932 total citations · 1 hit paper
20 papers, 679 citations indexed

About

Isao Moritani is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Isao Moritani has authored 20 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Isao Moritani's work include Venous Thromboembolism Diagnosis and Management (6 papers), Acute Ischemic Stroke Management (4 papers) and Sepsis Diagnosis and Treatment (4 papers). Isao Moritani is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Acute Ischemic Stroke Management (4 papers) and Sepsis Diagnosis and Treatment (4 papers). Isao Moritani collaborates with scholars based in Japan and China. Isao Moritani's co-authors include Katsuya Shiraki, Hidekazu Inoue, Junichiro Tanaka, Masahiko Tameda, Chika Kasai, Kojiro Takase, Kazushi Sugimoto, Masaaki Ito, Yoshiyuki Takei and Yumi Oya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Gastroenterology and Hepatology.

In The Last Decade

Isao Moritani

19 papers receiving 671 citations

Hit Papers

Comparison of the gut microbiota composition between obes... 2015 2026 2018 2022 2015 100 200 300 400

Peers

Isao Moritani
Guido J. Bakker Netherlands
Ilias Attaye Netherlands
Laura A. Bolte Netherlands
Philippa M. Wells United Kingdom
Isao Moritani
Citations per year, relative to Isao Moritani Isao Moritani (= 1×) peers Chika Kasai

Countries citing papers authored by Isao Moritani

Since Specialization
Citations

This map shows the geographic impact of Isao Moritani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Moritani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Moritani more than expected).

Fields of papers citing papers by Isao Moritani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Moritani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Moritani. The network helps show where Isao Moritani may publish in the future.

Co-authorship network of co-authors of Isao Moritani

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Moritani. A scholar is included among the top collaborators of Isao Moritani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Moritani. Isao Moritani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moritani, Isao, et al.. (2025). Prevalence of and risk factors for long COVID following infection with the COVID‑19 omicron variant . PubMed. 5(2). 17–17. 1 indexed citations
2.
Ikeda, Kohei, Isao Moritani, Yutaka Yamanaka, et al.. (2025). Biliary microbiome profiling via 16 S rRNA amplicon sequencing in patients with cholangiocarcinoma, pancreatic carcinoma and choledocholithiasis. Scientific Reports. 15(1). 16966–16966. 1 indexed citations
3.
Wada, Hideo, Isao Moritani, Yutaka Yamanaka, et al.. (2024). Detection of Prethrombotic State Malignant Neoplasms, Including Pancreatic Cancer, Using Clot Waveform Analysis. Zenodo (CERN European Organization for Nuclear Research). 11(1). 1 indexed citations
4.
Wada, Hideo, Kohei Ikeda, Isao Moritani, et al.. (2024). Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis. Clinical and Applied Thrombosis/Hemostasis. 30. 3005427506–3005427506. 3 indexed citations
5.
Yamada, Reiko, Toji Murabayashi, Shinya Sugimoto, et al.. (2023). The safety and efficacy of Ringer's solution loading with rectal diclofenac for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis: The RESOLUTION‐PEP study. SHILAP Revista de lepidopterología. 3(1). e236–e236. 1 indexed citations
6.
Wada, Hideo, Katsuya Shiraki, Akitaka Yamamoto, et al.. (2023). Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases. Journal of Clinical Medicine. 12(7). 2597–2597. 4 indexed citations
7.
Moritani, Isao, Yutaka Yamanaka, Hidekazu Inoue, et al.. (2022). The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing. BMC Gastroenterology. 22(1). 313–313. 13 indexed citations
8.
Wada, Hideo, Akitaka Yamamoto, Jun Masuda, et al.. (2022). Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation. Journal of Clinical Medicine. 11(4). 1028–1028. 5 indexed citations
9.
Wada, Hideo, Motoko Tanaka, Katsuya Shiraki, et al.. (2022). D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases. Clinical and Applied Thrombosis/Hemostasis. 28. 2975252088–2975252088. 9 indexed citations
10.
Wada, Hideo, Akitaka Yamamoto, Masamichi Yoshida, et al.. (2022). Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019. Journal of Clinical Medicine. 11(4). 985–985. 13 indexed citations
11.
Wada, Hideo, Katsuya Shiraki, Isao Moritani, et al.. (2021). Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura. Journal of Clinical Medicine. 10(24). 5987–5987. 8 indexed citations
12.
Yamamoto, Akitaka, Hideo Wada, Jun Masuda, et al.. (2021). Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection. Journal of Clinical Medicine. 10(17). 3775–3775. 11 indexed citations
13.
Wada, Hideo, Katsuya Shiraki, Isao Moritani, et al.. (2021). A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms. Journal of Clinical Medicine. 10(22). 5352–5352. 13 indexed citations
14.
Wada, Hideo, Motoko Tanaka, Katsuya Shiraki, et al.. (2020). Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients. Clinical and Applied Thrombosis/Hemostasis. 26. 2874371612–2874371612. 15 indexed citations
15.
Mori, Naoyoshi, Isao Moritani, Yutaka Yamanaka, et al.. (2018). Second‑line triple therapy in failures with vonoprazan‑based triple therapy for eradication of Helicobacter pylori. Biomedical Reports. 9(2). 169–174. 14 indexed citations
16.
Kasai, Chika, Kazushi Sugimoto, Isao Moritani, et al.. (2016). Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. BMC Gastroenterology. 16(1). 119–119. 16 indexed citations
17.
Kasai, Chika, Kazushi Sugimoto, Isao Moritani, et al.. (2015). Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterology. 15(1). 100–100. 448 indexed citations breakdown →
19.
Hashimoto, Akira, Isao Moritani, Akira Shimizu, & Katsuya Shiraki. (2007). Hepatobiliary and pancreatic: Hepatic portal venous gas. Journal of Gastroenterology and Hepatology. 22(2). 277–277. 1 indexed citations
20.
Hashimoto, Akira, Isao Moritani, Atsushi Shimizu, & Katsuya Shiraki. (2006). Hepatobiliary and pancreatic: Oral therapy for pancreatic duct stones. Journal of Gastroenterology and Hepatology. 21(9). 1496–1496.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026